Backabrdn Life Sciences Investors Overview

abrdn Life Sciences Investors Current Cash

Latest current cash for HQL: $0.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$0.00

Peer average

Loading

abrdn Life Sciences Investors Current Cash History

Loading

abrdn Life Sciences Investors vs. peers: Current Cash Comparison

Loading

abrdn Life Sciences Investors Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

abrdn Life Sciences Investors (HQL) FAQ

abrdn Life Sciences Investors (HQL) currently reports a current cash of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore abrdn Life Sciences Investors's current cash history and peer comparisons.

abrdn Life Sciences Investors's current cash changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

abrdn Life Sciences Investors reported $0 in current cash as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for abrdn Life Sciences Investors, and consider following HQL for alerts when major investors trade the stock.